Loratadine and Flector drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Flector (diclofenac epolamine). Common drug interactions include night sweats among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Flector. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

On Aug, 08, 2026

26 people who take Loratadine and Flector together, and have interactions are studied.

Loratadine and Flector drug interactions.

What are the common drug interactions of Loratadine and Flector, by gender? *:

female:

Night sweats (sweating in night)
Nightmare (unpleasant dream)
Oedema peripheral (superficial swelling)
Pain in extremity
Patellofemoral pain syndrome (pain in the front of the knee)
Pelvic pain
Peripheral swelling
Personality disorder
Plantar fasciitis (painful inflammatory process of the plantar fascia)
Rash

male:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Emotional distress
Faecal incontinence (a lack of control over passing stool)
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Gait disturbance
Haemorrhage (bleeding)
Nephrogenic anaemia (anaemia due to kidney disease)
Rectal haemorrhage (bleeding from anus)
Renal failure (kidney dysfunction)

What are the common drug interactions of Loratadine and Flector, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alanine aminotransferase increased
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood bilirubin increased
Bone density decreased
Bone pain
Chronic kidney disease
Drug resistance (reduction in effectiveness of a drug)

50-59:

Dyskinesia (abnormality or impairment of voluntary movement)
Overweight
Pneumonia
Renal injury (kidney injury)
Chronic kidney disease
Diplopia (double vision)
Drug hypersensitivity
Dry eye (lack of adequate tears)
Dry mouth
Dysphagia (a condition in which swallowing is difficult or painful)

60+:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Constipation
Diarrhoea
Faecal incontinence (a lack of control over passing stool)
Fibromyalgia (a long-term condition which causes pain all over the body)
Gait disturbance
Haemorrhage (bleeding)
Injection site pain
Injection site swelling

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 30.77%
High Blood Cholesterol: 7 people, 26.92%
High Blood Pressure: 6 people, 23.08%
Sleep Disorder: 5 people, 19.23%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 15.38%
Cardiac Disorder: 4 people, 15.38%
Nausea (feeling of having an urge to vomit): 4 people, 15.38%
Depression: 4 people, 15.38%
Inflammation: 4 people, 15.38%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Flector?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously